» Articles » PMID: 1707922

Class I MHC-restricted Cytotoxic T Lymphocyte Recognition of Cells Infected with Human Cytomegalovirus Does Not Require Endogenous Viral Gene Expression

Overview
Journal J Immunol
Date 1991 Apr 15
PMID 1707922
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

The human pathogen CMV, is a major cause of morbidity and mortality in immunocompromised hosts. The CD8+ class I-restricted CTL response to CMV assists in preventing progression of CMV infection to life-threatening disease; however, the viral Ag recognized by CD8+ CTL are not well characterized. In general, virus-specific CTL recognize endogenously synthesized viral proteins processed and presented associated with class I MHC molecules. Although proteins or inactivated virions have been experimentally delivered to the cytoplasm to result in class I MHC presentation, this mode of Ag delivery to the class I processing pathway after natural viral entry has not been documented in humans. Our data demonstrate that the CMV-specific class I-restricted CTL response in individuals latently infected with CMV is predominantly specific for selected structural virion proteins introduced into the cell after viral penetration and efficient recognition occurs in the absence of de novo viral gene expression. This CTL response may provide a biological advantage for limiting the spread of infection after CMV reactivation because infected cells are lysed before viral assembly.

Citing Articles

Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects.

Shafer P, Kelly L, Hoyos V Front Immunol. 2022; 13:835762.

PMID: 35309357 PMC: 8928448. DOI: 10.3389/fimmu.2022.835762.


Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation.

Zamora D, Duke E, Xie H, Edmison B, Akoto B, Kiener R Blood. 2021; 138(1):34-43.

PMID: 33657225 PMC: 8493975. DOI: 10.1182/blood.2020009396.


Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma.

Xu Y, Morales A, Cargill M, Towlerton A, Coffey D, Warren E Cancer Immunol Immunother. 2019; 68(12):1979-1993.

PMID: 31686124 PMC: 6877496. DOI: 10.1007/s00262-019-02419-4.


TRAV1-2 CD8 T-cells including oligoconal expansions of MAIT cells are enriched in the airways in human tuberculosis.

Wong E, Gold M, Meermeier E, Xulu B, Khuzwayo S, Sullivan Z Commun Biol. 2019; 2:203.

PMID: 31231693 PMC: 6549148. DOI: 10.1038/s42003-019-0442-2.


Human cytomegalovirus-specific T-cell receptor engineered for high affinity and soluble expression using mammalian cell display.

Wagner E, Qerqez A, Stevens C, Nguyen A, Delidakis G, Maynard J J Biol Chem. 2019; 294(15):5790-5804.

PMID: 30796163 PMC: 6463697. DOI: 10.1074/jbc.RA118.007187.